The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1236
ISSUE1236
June 5, 2006
Ranolazine (Ranexa) for Chronic Angina
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Ranolazine (Ranexa) for Chronic Angina
June 5, 2006 (Issue: 1236)
The FDA has approved the marketing of extended release (ER) ranolazine (Ranexa - CV Therapeutics) for treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs. It should be used in combination...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.